三联疗法与胃炎灵联合治疗胃溃疡幽门螺杆菌感染的临床研究

骆定海; 毛鑫礼; 邵颖颖; 杨海登

doi:10.3969/j.issn.1671-038X.2017.02.07

三联疗法与胃炎灵联合治疗胃溃疡幽门螺杆菌感染的临床研究

- 台州医院消化内科, 浙江台州 317000

详细信息

作者简介:
骆定海,男,硕士,副主任医师,研究方向:胃肠道疾病,内镜下微创治疗

通讯作者: 毛鑫礼,E-mail:maoxl@enzemed.com

中图分类号: R573.6

收稿日期: 2016-09-08

Clinical study on treatment of helicobacter pylori infection with gastric ulcer by combined therapies

- Department of Gastroenterology, Zhejiang Taizhou Hospital, Taizhou 317000, China

More Information

Corresponding author: MAO Xin-li, E-mail: maoxl@enzemed.com

Received Date: 08 September 2016

摘要

摘要: [目的]探究对胃溃疡幽门螺杆菌（Hp）感染患者采用三联疗法联合胃炎灵进行治疗的临床效果。[方法]选择2014年2月~2016年2月于我院接受治疗的胃溃疡Hp感染患者中随机选取91例作为此次研究的观察对象，并按照入院治疗的先后顺序将其分为研究组（45例）和对照组（46例），2组的治疗方案分别为三联疗法联合胃炎灵和单纯使用三联疗法，疗程结束后对患者的治疗效果进行观察与分析。[结果]经治疗，研究组的总有效率、Hp根除率和复发率分别为93.33%、97.78%、4.44%；对照组分别为76.09%、71.74%、19.57%，2组数据比较，差异有统计学意义（P<0.05）。研究组的各个临床症状评分均低于对照组，且差异有统计学意义（P<0.05）。[结论]对胃溃疡Hp感染患者采用三联疗法与胃炎灵进行联合治疗效果显著，临床推广价值高。
- 三联疗法 /
- 胃炎灵 /
- 联合 /
- 治疗 /
- 胃溃疡幽门螺杆菌感染
Abstract: [Objective] To explore the clinical effect of triple therapy combined with Weiyanling in patients with gastric ulcer and Helicobacter pylori infection.[Methods] From February 2014 to February 2016, 91 patients with Helicobacter pylori(H.pylori) infection in our hospital were randomly selected and divided into two groups according to the order of hospitalization:treatment group(n=45) and control group(n=46).The treatment regimen of the two groups was triple therapy combined with Weiyanling and the triple therapy was used alone.After treatment, the therapeutic effect was observed and analyzed.[Results] The total effective rate, Hp eradication rate and recurrence rate of the treatment group were 93.33%, 97.78% and 4.44% respectively.The corresponding values of the control group were 76.09%, 71.74% and 19.57%(P<0.05).The clinical symptom scores of the treatment group were lower than those of the control group, and the differences were statistically significant(P<0.05).[Conclusion] Combination of triple therapy and Weiyanling treatment is effective in the treatment of gastrie ulcer patients with Helicobacter pylori infection.
- triple therapy /
- gastritis /
- combination /
- treatment /
- gastric ulcer Helicobacter pylori infection

HTML全文

参考文献(8)

[1]	陈伟.甲硝唑联合左氧氟沙星治疗幽门螺杆菌感染的临床效果分析[J].中国医药指南, 2014, 14(10):26-27.
[2]	杨红.联合用药治疗胃溃疡幽门螺杆菌感染的疗效探究[J].母婴世界, 2015, 3(3):201.
[3]	付荣.埃索美拉唑联合阿莫西林、克拉霉素治疗胃溃疡幽门螺杆菌感染的临床观察[J].临床合理用药, 2014, 7(6):53.
[4]	范跃峰.安胃汤与泮托拉唑治疗幽门螺杆菌感染胃溃疡44例[J].陕西中医, 2014, 35(7):837-838.
[5]	刘双亮.铝碳酸镁联合兰索拉唑钠三联疗法治疗幽门螺杆菌相关性胃溃疡的疗效观察[J].现代实用医学, 2014, 26(9):1100-1102.
[6]	Sugimoto M, Yamaoka Y.Virulence factor genotypes of Helicobacter pylori affect cure rates of eradication therapy[J].Arch Immunol Ther Exp(Warsz), 2009, 57(1):45-46.
[7]	李虹.三联疗法联合胃炎灵治疗胃溃疡幽门螺杆菌感染的临床观察[J].医学信息, 2015, 28(50):311-312.
[8]	谭昊.三联疗法与胃炎灵联合治疗胃溃疡幽门螺杆菌感染60例的临床研究[J].临床医学工程, 2014, 21(12):1579-1580.